Evaluation of Therapeutic Strategies for Treatment of Ectopic Pregnancies (EP) and Evaluation of Subsequent Fertility
Prospective Study, Randomized Controlled Trial Between Medical Treatment by Methotrexate Versus Conservative Surgical Treatment (Group 1) and Conservative Versus Radical Surgical Treatment (Group 2) to Evaluate Subsequent Fertility
1 other identifier
interventional
600
1 country
18
Brief Summary
Three protocols are used to treat ectopic pregnancies: medical treatment by methotrexate, conservative surgery or radical surgery. There are no data about subsequent fertility except in a cohort study. The investigators propose to evaluate the true subsequent fertility with a follow-up of 2 years, in a randomized controlled trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Aug 2004
Longer than P75 for phase_4
18 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2004
CompletedFirst Submitted
Initial submission to the registry
August 29, 2005
CompletedFirst Posted
Study publicly available on registry
August 30, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2008
CompletedSeptember 8, 2006
August 1, 2005
August 29, 2005
September 7, 2006
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Subsequent fertility with 2 years follow-up
Secondary Outcomes (4)
Complications of treatments
Time of hospitalisation
Decrease curve of beta-hCG after treatment
Success rate in each group
Interventions
Eligibility Criteria
You may qualify if:
- Diagnosis by ultra sound of ectopic pregnancy (EP)
- Patients aged \> 18 years old
- Desire of future pregnancy
You may not qualify if:
- EP by failure of contraception
- EP associated with in vitro fertilization (IVF)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (18)
Angers Hospital
Angers, 49033, France
Antoine Beclere Hospital
Clamart, 92140, France
Créteil Hospital
Créteil, 94000, France
Franco-Britannique Hospital
Levallois-Perret, 92300, France
Jeanne de Flandre Hospital
Lille, 59037, France
Hôtel Dieu
Lyon, 69288, France
Assistance Publique Hôpitaux de Marseille ; Maternité de la Conception
Marseille, 13005, France
Assistance Publique Hôpitaux de Marseille ; Hôpital Nord
Marseille, 13326, France
Maternité Régionale de Nancy
Nancy, 54042, France
Nantes Hospital
Nantes, 44093, France
Lariboisière Hospital
Paris, 75010, France
Cochin Hospital
Paris, 75679, France
Poissy Saint-Germain-en-Laye Hospital
Poissy, 78303, France
Roubaix Hospital
Roubaix, 59100, France
Charles Nicolle Hospital
Rouen, 76031, France
CMCO
Schiltigheim, 67303, France
Tours Hospital
Tours, 37000, France
Versailles Hospital ; Hôpital André Mignot
Versailles, 78157, France
Related Publications (3)
Fernandez H, Gervaise A. Ectopic pregnancies after infertility treatment: modern diagnosis and therapeutic strategy. Hum Reprod Update. 2004 Nov-Dec;10(6):503-13. doi: 10.1093/humupd/dmh043. Epub 2004 Sep 23.
PMID: 15388673BACKGROUNDBourel G, Pelletier-Fleury N, Bouyer J, Delbarre A, Fernandez H, Capmas P. Cost-effectiveness analysis of medical management versus conservative surgery for early tubal pregnancy. Hum Reprod. 2019 Feb 1;34(2):261-267. doi: 10.1093/humrep/dey352.
PMID: 30520964DERIVEDFernandez H, Capmas P, Lucot JP, Resch B, Panel P, Bouyer J; GROG. Fertility after ectopic pregnancy: the DEMETER randomized trial. Hum Reprod. 2013 May;28(5):1247-53. doi: 10.1093/humrep/det037. Epub 2013 Mar 12.
PMID: 23482340DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Fernandez Hervé, PhD MD
Hopital Antoine Beclere
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 29, 2005
First Posted
August 30, 2005
Study Start
August 1, 2004
Study Completion
July 1, 2008
Last Updated
September 8, 2006
Record last verified: 2005-08